前列腺癌中的心血管风险
Darryl P Leong1, Filipe Cirne2, Jehonathan H Pinthus3
1Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada; Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, Canada.
Cardiology clinics
|November 17, 2024
概括
患有前列腺癌的患者经常患有心血管疾病,这是导致死亡的主要原因. 像抗雄激素剥夺疗法 (ADT) 这样的治疗可能会增加心血管风险,需要进一步研究和遵守指南.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 心血管疾病 (CVD) 在前列腺癌患者中非常普遍,是死亡的重要原因.
- 根据当前的指导方针,该人群中现有的心血管风险因素往往未得到充分治疗.
- 安卓素剥夺疗法 (ADT) 是一种常见的前列腺癌治疗方法,与可能增加心血管疾病风险的代谢变化有关.
研究的目的:
- 评估前列腺癌患者的雄激素剥夺疗法 (ADT) 和心血管不良事件之间的关系.
- 评估与雄激素受体信号传递抑制剂和CYP17A1抑制剂相关的潜在增量心血管风险.
- 为了检查性腺激素释放激素对抗剂和激动剂之间的心血管风险比较.
主要方法:
- 对有关前列腺癌治疗方法和心血管结果的现有文献和临床数据的审查.
- 分析ADT对心血管风险因素 (如糖尿病和高血压) 的影响.
- 探索不同类型的荷尔蒙疗法 (包括抑制剂) 的心血管安全概况.
主要成果:
- ADT与脂肪增加和糖尿病和高血压风险增加有关,尽管其与心血管事件的直接关联需要进一步确认.
- 雄激素受体信号抑制剂和CYP17A1抑制剂可能会增加ADT患者高血压和心血管事件的风险.
- 初步证据表明,与激动剂相比,性腺激素释放激素抗剂可能会降低心血管风险,需要确认.
结论:
- 心血管风险管理对于前列腺癌患者至关重要,特别是那些接受ADT的患者.
- 特定的荷尔蒙疗法可能会影响心血管事件的发生率,需要对患者进行仔细的选择和监测.
- 需要进一步的随机临床试验来确认不同ADT药物的心血管安全性.
相关概念视频
01:20Disorders of the Male Reproductive System
337
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
337
01:27Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
60
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
60
01:20Exercise and Cardiovascular Response
739
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
739
01:23Assessment of the Cardiovascular System I: Subjective Data
280
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
280
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103